Mirae Asset Global Investments
DFTX

Mirae Asset Global Investments’s Definium Therapeutics DFTX Stock Holding History

Mirae Asset Global Investments’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$229K Sell
4,878
-322
-6% -$7.96K ﹤0.01% 1101
2026
Q1 		$98.3K Buy
+5,200
New +$88.2K ﹤0.01% 1184
2025
Q4 		– Sell
-2,942
Closed -$34.7K – 1707
2025
Q3 		$34.7K Buy
2,942
+23
+0.8% +$214 ﹤0.01% 1403
2025
Q2 		$18.9K Buy
2,919
+465
+19% +$3.06K ﹤0.01% 1405
2025
Q1 		$15.2K Buy
2,454
+10
+0.4% +$72 ﹤0.01% 1417
2024
Q4 		$16.7K Buy
+2,444
New +$16.8K ﹤0.01% 1445

Other funds holding DFTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $26.6B AUM
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Mirae Asset Global Investments's DFTX Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Definium Therapeutics (DFTX) stake by 6.2% in Q2 2026, selling an estimated $7.96K and leaving 4,878 shares worth $229K. The position accounts for ﹤0.01% of the portfolio, ranked #1101.

Mirae Asset Global Investments first reported a position in DFTX in Q4 2024 and has held it in 6 quarters since. 129 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

  • Mirae Asset Global Investments held 4,878 shares of Definium Therapeutics worth $229K as of Q2 2026.
  • Mirae Asset Global Investments sold 322 Definium Therapeutics shares in Q2 2026, an estimated $7.96K.
  • Definium Therapeutics made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1101 holding.
  • Mirae Asset Global Investments first reported a position in Definium Therapeutics in Q4 2024 and has held it in 6 quarters since.
  • 129 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.